SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision
Colorectal Disease · 2025-02 · 27 (2)
DOI: 10.1111/codi.70009 ↗At a glance
Randomisierte kontrollierte Studie in Colorectal Disease, published online on 2025-01-30. Written by Martin Rutegård and 11 co-authors. Institution: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Major MEDLINE topics: Anastomotic Leak, Proctectomy, Rectal Neoplasms, Surgical Stomas. Cited 12 times so far (Crossref); 29 references. The full text is freely available (open access, CC BY 4.0). Funded by: Swedish Research Council, Cancerfonden, Vetenskapsrådet.
Abstract (original language)
Aim
Accumulated data suggest that routine use of defunctioning stoma in low anterior resection for rectal cancer may cause kidney injury, bowel dysfunction and a higher risk of permanent stomas. We aim to study whether avoidance of a diverting stoma in selected patients is safe and reduces adverse consequences.
Methods
SELSA is a multicentre international prospective observational study nesting an open‐label randomized clinical trial. All patients with primary rectal cancer planned for low anterior resection are eligible. Patients operated with curative intent, aged
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden.
- Department of Surgery, Ryhov County Hospital, Jönköping, Sweden.
- Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Department of Surgery, Faculty of Medicine and Health Sciences, Örebro University, Örebro, Sweden.
- Department of Gastrointestinal Surgery, Haukeland University Hospital, Bergen, Norway.
ORCID profiles: Martin Rutegård, Marcus Lindsköld, Fredrik Jörgren, Kalle Landerholm, Peter Matthiessen, Håvard Mjørud Forsmo, Jennifer Park, Jacob Rosenberg, Johannes Schultz, Lars T Seeberg, Josefin Segelman, Pamela Buchwald
Funding
- Swedish Research Council
- Cancerfonden
- Vetenskapsrådet
Cite
APA
Rutegård, M., Lindsköld, M., Jörgren, F., Landerholm, K., Matthiessen, P., Forsmo, H. M., Park, J., Rosenberg, J., Schultz, J., Seeberg, L. T., Segelman, J., & Buchwald, P. (2025). SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision. Colorectal Disease, 27(2). https://doi.org/10.1111/codi.70009
Vancouver
Rutegård M, Lindsköld M, Jörgren F, Landerholm K, Matthiessen P, Forsmo HM, et al. SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision. Colorectal Disease. 2025;27(2). doi:10.1111/codi.70009
BibTeX
@article{Rutegrd2025,
author = {Rutegård, Martin and Lindsköld, Marcus and Jörgren, Fredrik and Landerholm, Kalle and Matthiessen, Peter and Forsmo, Håvard Mjørud and Park, Jennifer and Rosenberg, Jacob and Schultz, Johannes and Seeberg, Lars T and Segelman, Josefin and Buchwald, Pamela},
title = {SELective defunctioning Stoma Approach in low anterior resection for rectal cancer (SELSA): Protocol for a prospective study with a nested randomized clinical trial investigating stoma‐free survival without major LARS following total mesorectal excision},
journal = {Colorectal Disease},
year = {2025},
volume = {27},
number = {2},
doi = {10.1111/codi.70009}
}
EUVIMED